Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Asset Sale | AssetsPurchased

Total Raised


About Cutanix

Developer of topical dermatological drugs. The company's products are based on novel compounds that regulate the molecular biology of the skin in beneficial ways. Using advanced cell and molecular biology research techniques available to discover these compounds, the company formulates them into topical products for the professional skincare, prestige cosmetic, and prescription dermatology markets.

Cutanix Headquarter Location

5150 El Camino Real Suite B-18

Los Altos, California, 94022,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.